MAPK9 and diabetes mellitus: Evidence has shown that diabetes‐induced oxidative stress is related to JNK activation and Nrf2 inhibition, and suppression of JNK activates Nrf2.3 Consistent with the literature, we demonstrated that both C66 treatment and JNK2 deletion activated Nrf2.